Zalviso (sufentanil NanoTab PCA System)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Zalviso (sufentanil NanoTab PCA System), covering 2014-03-27 to 2014-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter, Randomized, Open-Label, Parallel-Group Trial to Compare the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™)to Intravenous Patient-Controlled Analgesia With Morphine for the Treatment of Acute Post-Operative Pain [Phase 3]